Despite the recommendations of the trade unions, the vaccine that protects adults is not available in Israel
The United States, the United Kingdom, France and other Western countries are recommending that people aged 65 and over be vaccinated with an increased dose of the flu virus that has returned this year to break out and cause serious illness. Despite recommendations worldwide,
Monday, 20 December 2021, 12:34 Updated: Tuesday, 21 December 2021, 19:19
Share on Facebook
Share on WhatsApp
Share on Twitter
Share on Email
Share on general
In the video: The Prime Minister on the third vaccine (Walla system!)
In recent days the inpatient departments of hospitals have been overloaded with flu patients. According to data from the National Center for Disease Control, as of last week, 565 patients have been reported hospitalized since the beginning of the season after being diagnosed with the disease. The flu virus can cause serious illness, such as pneumonia, other respiratory complications, myocarditis and even death. Nevertheless, despite the fact that new vaccines have been developed that provide greater and more significant protection against the flu and its associated complications, Israel does not adopt the new vaccine and is content with the usual vaccines.
In Israel, in recent years, about 60% of the elderly population has been vaccinated against the flu virus.
Despite this, almost two-thirds of flu-related hospitalizations are of the elderly and 90% of flu deaths are among those aged 65 and over.
Hospitalization and mortality rates associated with influenza rise significantly during the seventh and eighth decade of life.
Influenza is known to aggravate the condition of chronic diseases, including heart failure, chronic obstructive pulmonary disease, asthma and diabetes.
Influenza can also lead to secondary infections, including pneumonia, sinus infections and ear infections.
Over the years, there is a decrease in the functioning of the body's immune system and therefore the elderly are more prone to infectious diseases and the vaccines become less effective for them.
More on Walla!
Bennett: A fourth corona vaccine is being considered for at-risk populations
To the full article
More on Walla!
Horowitz in implicit criticism of Lieberman: "There will be no restrictions without compensation, we will insist with the Treasury"
Senior Ministry of Health: To prepare for limiting gatherings and additional vaccination for recovering people
Closing a year with a huge sale on STINGTV for a limited time
HMOs do not provide it to the population at risk for complications. A man gets vaccinated in Ramat Gan, September (Photo: Reuven Castro)
In recent years, new vaccines have been developed that provide greater and more significant protection against the flu and its associated complications. Vaccines developed to protect the elderly population include the "Fluzone HD" vaccine. This is a vaccine that contains four times the substance found (maglutinin) in the regular flu vaccine given every year in Israel. The "Ploson" vaccine is effective against four strains, including against influenza A - the most common time identified this year.
The advantage of a high-dose ("Ploson" vaccine) compared to a regular-dose vaccine is its high efficacy. According to studies published worldwide, Pelvon reduced all influenza morbidity by 24.2% compared to the standard vaccine. Despite the increased dose of the active ingredient, the vaccine is considered safe to use. Studies show that the safety profile of the "Ploson" vaccine in adults aged 65 and over was similar to the regular flu vaccines. The vaccine has few mild side effects like redness,Swelling or pain at the injection site.
Influenza Vaccine Complex, September (Photo: Reuven Castro)
In recent years, more and more professional unions around the world have begun to recommend high-dose vaccines for the adult population.
Just last month the British Vaccine Commission announced that it is recommending the entire adult population in the UK to be vaccinated starting next year on a vaccine that includes an increased dose.
The UK Vaccine Committee's recommendation joins the recommendations of the US Centers for Disease Control and Prevention (CDC), which a decade ago recommended that 65-year-olds be vaccinated with increased doses and that about 70 percent of the adult population in the United States be vaccinated.
More and more health bodies around the world are recommending that adults receive the increased vaccine, including the Ministry of Health in Canada, the German Immunization Commission, the Austrian Ministry of Health, the Geriatric Association in France and other countries such as Denmark, Spain, Italy and Sweden.
Although many countries have adopted the recommendation and provide their citizens with a vaccine that better protects the elderly population, in Israel there is no such recommendation and the Ministry of Health and the HMOs - with the exception of Meuhedet - do not provide the vaccine to the population aged 65 and over. Last year, when there was concern about the combination of Corona and influenza, all HMOs purchased about a quarter of a million vaccine doses, but this year, when there is a serious flu outbreak, the HMOs did not prepare properly and gave up the vaccine that could protect the at-risk population.
Last week the Ministry of Health announced that local outbreaks of influenza virus morbidity have recently been identified in various centers in the community across the country.
The disease has been reported in children, adolescents, and young adults.
Not only in Israel is there an increase in morbidity but also in the United States.
According to the CDC (American Center for Disease Research and Control) this winter the type A flu strain (H3N2) accounts for the majority of cases.
According to the organization, the flu seems to be returning after last year almost no biblical morbidity was reported.
"Although influenza activity is low in most of the state, the United States now sees more flu activity than during the entire past season," the report said. The effect of the year.